Dec 04, 2019 / 01:30PM GMT
Unidentified Analyst
Good morning, everyone. Thanks very much for being here and welcome to the second day of the 31st Annual Piper Jaffray Healthcare Conference. With us for this session, we're very pleased to have Incyte in attendance. And from Incyte, we have Hervé Hoppenot, the Chairman and President and CEO; and Christiana Stamoulis, the Executive Vice President and CFO.
Questions and Answers:
Unidentified AnalystSo Hervé, as evidenced by the current stock price, you guys have had a pretty good year. And in addition to continuing to execute on the Jakafi Jakavi launch, and executing on the pipeline and the post IDO era, I thought it would be helpful just to start by discussing your confidence in the existing Jakavi Jakafi franchise and the breadth of the pipeline and the overall state of the business.
HervéHoppenot - Incyte Corporation - Chairman, President & CEO
Okay. Thank you. Thank you for having us here. So when you look at the portfolio of Incyte today, so you have the existing Jakafi franchise
Trustpilot
